Minnesota SF 917: Pharmacy benefit manager business practices modification and general reimbursement practices establishment; maximum allowable cost pricing requirements modification

Status: Comm report: To pass as amended and re-refer to Health and Human Services Finance and Policy (as of 2021-03-17)

State: Minnesota · Session: 2021-2022 · Bill: SF 917

Subjects: Drugs and Medicine, Health and Health Department

Sponsors: Draheim, Klein, Tomassoni, Utke, Wiklund

View Minnesota SF 917 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.